Accumulating evidence implicates S1P signaling as a pivotal regulator in the immunopathogenesis of autoimmune disorders including multiple sclerosis (MS), rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE) [57,58,59]. This evidence concerns the gene MBTPS1 and rheumatoid arthritis.